Nykredit A/S’s CVS Health CVS Stock Holding History

Nykredit A/S’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210M	Buy	+2,028,154	New	+$181M	0.8%	18

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nykredit A/S's CVS Position: Q2 2026 in Review

Nykredit A/S opened a new position in CVS Health (CVS) in Q2 2026: 2,028,154 shares worth $210M. The stake represents 0.8% of the portfolio and ranks #18 among its holdings.

2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Nykredit A/S held 2,028,154 shares of CVS Health worth $210M as of Q2 2026.
CVS Health was a new Nykredit A/S position in Q2 2026.
CVS Health made up 0.8% of Nykredit A/S's portfolio in Q2 2026, its #18 holding.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.